PCSK9 and coronary artery disorder: Hence, these studies have shown that PCSK9 is associated with the occurrence of inflammation in the occurrence and development of CAD, suggesting that inhibition of PCSK9 may have a therapeutic effect on atherosclerotic inflammation and CAD.